Evaluating the immunogenicity of a mouse partial hindlimb for composite allotransplantation

This study provides valuable insights into acute rejection in VCA using a novel mouse hindlimb transplant model. Findings reveal immune response complexity, with increased CD8+ T cells and Tr1 cells in allogeneic skin, and unexpected vascularization in non-vascularized grafts. The rise in Tr1 cells suggests a potential mechanism for immune regulation, offering potential for tolerance induction strategies. These results emphasize the need for tissue-specific immunosuppressive approaches, where targeting Tr1 cells could reduce dependence on broad immunosuppression, improving long-term graft survival and patient outcomes. This work lays the foundation for refining VCA therapies, with more personalized, less toxic immunosuppressive strategies.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-06-18
DOI
https://doi.org/10.3389/fimmu.2025.1595319
Primary Topic
Organ and Tissue Transplantation Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating the immunogenicity of a mouse partial hindlimb for composite allotransplantation

Siba Haykal, Felor Biniazan, Jing Sun, Samantha Ligi
Frontiers in Immunology
Organ and Tissue Transplantation Research
article

Evaluating the immunogenicity of a mouse partial hindlimb for composite allotransplantation

Siba Haykal, Felor Biniazan, Jing Sun, Samantha Ligi
article en

Abstract

This study provides valuable insights into acute rejection in VCA using a novel mouse hindlimb transplant model. Findings reveal immune response complexity, with increased CD8+ T cells and Tr1 cells in allogeneic skin, and unexpected vascularization in non-vascularized grafts. The rise in Tr1 cells suggests a potential mechanism for immune regulation, offering potential for tolerance induction strategies. These results emphasize the need for tissue-specific immunosuppressive approaches, where targeting Tr1 cells could reduce dependence on broad immunosuppression, improving long-term graft survival and patient outcomes. This work lays the foundation for refining VCA therapies, with more personalized, less toxic immunosuppressive strategies.

Frontiers in ImmunologyVol. 16
University Health Network (CA), University of Toronto (CA), Yale University (US), Yale New Haven Health System (US)
Openalex Percentile: Top 82%
Organ and Tissue Transplantation Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.